BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24680120)

  • 21. Breast MR imaging: computer-aided evaluation program for discriminating benign from malignant lesions.
    Williams TC; DeMartini WB; Partridge SC; Peacock S; Lehman CD
    Radiology; 2007 Jul; 244(1):94-103. PubMed ID: 17507720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up.
    Hambly NM; Liberman L; Dershaw DD; Brennan S; Morris EA
    AJR Am J Roentgenol; 2011 Jan; 196(1):218-24. PubMed ID: 21178070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiation of ovarian endometriomas from hemorrhagic cysts at MR imaging: utility of the T2 dark spot sign.
    Corwin MT; Gerscovich EO; Lamba R; Wilson M; McGahan JP
    Radiology; 2014 Apr; 271(1):126-32. PubMed ID: 24475842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical significance of breast MRI in the management of ductal carcinoma in situ diagnosed on needle biopsy.
    Miyashita M; Amano G; Ishida T; Tamaki K; Uchimura F; Ono T; Yajima M; Kuriya Y; Ohuchi N
    Jpn J Clin Oncol; 2013 Jun; 43(6):654-63. PubMed ID: 23592884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
    Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
    Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic resonance imaging enhancement features before and after neoadjuvant chemotherapy in patients with breast cancer: a predictive value for responders.
    Kang DK; Kim TH; Han TS; Kim KS; Yim H
    J Comput Assist Tomogr; 2013; 37(3):432-9. PubMed ID: 23674017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonsurgical management of high-risk lesions diagnosed at core needle biopsy: can malignancy be ruled out safely with breast MRI?
    Linda A; Zuiani C; Furlan A; Lorenzon M; Londero V; Girometti R; Bazzocchi M
    AJR Am J Roentgenol; 2012 Feb; 198(2):272-80. PubMed ID: 22268168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissected sentinel lymph nodes of breast cancer patients: characterization with high-spatial-resolution 7-T MR imaging.
    Korteweg MA; Zwanenburg JJ; Hoogduin JM; van den Bosch MA; van Diest PJ; van Hillegersberg R; Eijkemans MJ; Mali WP; Luijten PR; Veldhuis WB
    Radiology; 2011 Oct; 261(1):127-35. PubMed ID: 21673230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noninvasive nodal staging in patients with breast cancer using gadofosveset-enhanced magnetic resonance imaging: a feasibility study.
    Schipper RJ; Smidt ML; van Roozendaal LM; Castro CJ; de Vries B; Heuts EM; Keymeulen KB; Wildberger JE; Lobbes MB; Beets-Tan RG
    Invest Radiol; 2013 Mar; 48(3):134-9. PubMed ID: 23262788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The necrosis sign in magnetic resonance-mammography: diagnostic accuracy in 1,084 histologically verified breast lesions.
    Dietzel M; Baltzer PA; Vag T; Herzog A; Gajda M; Camara O; Kaiser WA
    Breast J; 2010; 16(6):603-8. PubMed ID: 21070437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High cancer yield and positive predictive value: outcomes at a center routinely using preoperative breast MRI for staging.
    Gutierrez RL; DeMartini WB; Silbergeld JJ; Eby PR; Peacock S; Javid SH; Lehman CD
    AJR Am J Roentgenol; 2011 Jan; 196(1):W93-9. PubMed ID: 21178040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of initially only magnetic resonance mammography-detected findings with and without correlate at second-look sonography: distribution according to patient history of breast cancer and lesion size.
    Linda A; Zuiani C; Londero V; Bazzocchi M
    Breast; 2008 Feb; 17(1):51-7. PubMed ID: 17709249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancellation of MR imaging-guided breast biopsy due to lesion nonvisualization: frequency and follow-up.
    Brennan SB; Sung JS; Dershaw DD; Liberman L; Morris EA
    Radiology; 2011 Oct; 261(1):92-9. PubMed ID: 21852565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequency, upgrade rates, and characteristics of high-risk lesions initially identified with breast MRI.
    Strigel RM; Eby PR; Demartini WB; Gutierrez RL; Allison KH; Peacock S; Lehman CD
    AJR Am J Roentgenol; 2010 Sep; 195(3):792-8. PubMed ID: 20729462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small (≤1-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging.
    Yu MH; Kim JH; Yoon JH; Kim HC; Chung JW; Han JK; Choi BI
    Radiology; 2014 Jun; 271(3):748-60. PubMed ID: 24588677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
    J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pleomorphic adenoma of the major salivary glands: diagnostic utility of FNAB and MRI.
    Heaton CM; Chazen JL; van Zante A; Glastonbury CM; Kezirian EJ; Eisele DW
    Laryngoscope; 2013 Dec; 123(12):3056-60. PubMed ID: 23798340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in Fatty and dense breasts using the whole-breast pathologic examination as a gold standard.
    Sardanelli F; Giuseppetti GM; Panizza P; Bazzocchi M; Fausto A; Simonetti G; Lattanzio V; Del Maschio A;
    AJR Am J Roentgenol; 2004 Oct; 183(4):1149-57. PubMed ID: 15385322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancelation of MRI guided breast biopsies for suspicious breast lesions identified at 3.0 T MRI: reasons, rates, and outcomes.
    Johnson KS; Baker JA; Lee SS; Soo MS
    Acad Radiol; 2013 May; 20(5):569-75. PubMed ID: 23473719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.